Abstract
Hereditary Angioedema with Normal C1 Inhibitor (C1INH) was first described in 2000. It affects both genders with higher prevalence of females due to hormonal influence. Symptoms have been associated with increased bradykinin and part of the patients present factor 12 mutation. Although knowledge about the mechanism involved is limited, HAE therapy with C1INH deficiency has been proposed b…